Stock comparison
AbbVie Inc. is 205.5x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($438.31 B vs $2.13 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 205.5x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($438.31 B vs $2.13 B).
Market value leader
ABBV
AbbVie Inc. is 205.5x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($438.31 B vs $2.13 B).
Revenue leader
ABBV
HRMY: $868.45M vs ABBV: $61.16B.
Profit leader
ABBV
HRMY: $158.69M vs ABBV: $4.23B.
Margin leader
HRMY
HRMY: 18.3% vs ABBV: 6.9% net margin.
| Metric | HRMY | ABBV |
|---|---|---|
| Market cap | $2.13 B | $438.31 B |
| US-listed rank | #2078 | #26 |
| Revenue (latest FY) | $868.45M | $61.16B |
| Net income (latest FY) | $158.69M | $4.23B |
| Net margin | 18.3% | 6.9% |
| P/E (trailing FY) | 13.4x | 103.7x |
| SEC filings | 434 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 205.5x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($438.31 B vs $2.13 B).
In their latest fiscal years, Harmony Biosciences Holdings, Inc. reported $868.45M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Harmony Biosciences Holdings, Inc. and AbbVie Inc., or browse the full rankings.